Literature DB >> 31637704

Circular RNA circFNDC3B protects renal carcinoma by miR-99a downregulation.

Tao Chen1, Qinchao Yu1, Shixiu Shao1, Lei Guo1.   

Abstract

Various circular RNAs (circRNAs) have been reported to involve in carcinoma. This study explored the role and mechanism of circRNA circFNDC3B (circFNDC3B) in renal carcinoma (RC). The detection indicators in this paper were viability, colony, and migration, which respectively investigated by Cell Counting Kit-8, colony formation, and migration assay. Reverse transcriptase quantitative polymerase chain reaction tested and cell transfection changed circFNDC3B and miR-99a expression. Moreover, western blot tested relate-proteins of proliferation, migration, and cell pathways were examined by western blot. circFNDC3B was upregulated at RC tissues. circFNDC3B enhanced cell viability, colony and migration, and miR-99a mimic played reverse impacts. Furthermore, circFNDC3B negatively regulated miR-99aand circFNDC3B restrained the janus kinase 1/signal transducer and activator of transcription 3 (JAK1/STAT3) and extracellular signal-regulated kinase (ERK) kinase (MEK)/ERK pathways by miR-99a downregulation. Overexpression of circFNDC3B enhanced cell viability, colony formation and migration by miR-99a downregulation via JAK1/STAT3 and MEK/ERK pathways.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  circFNDC3B; miR-99a; migration; renal carcinoma; viability

Mesh:

Substances:

Year:  2019        PMID: 31637704     DOI: 10.1002/jcp.29316

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  9 in total

Review 1.  The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.

Authors:  Hui Huang; Tao Chen; Fei Li; Dan Jin; Chuan Li; Yongbo Yang; Xuyang Liu; Dongmiao Wang; Jiehui Di
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

2.  The Use of circRNAs as Biomarkers of Cancer.

Authors:  Carla Solé; Gartze Mentxaka; Charles H Lawrie
Journal:  Methods Mol Biol       Date:  2021

Review 3.  CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma.

Authors:  Yuxia Zhou; Cheng Li; Zhenping Wang; Shuangfeng Tan; Yiqi Liu; Hu Zhang; Xuefeng Li
Journal:  Front Mol Biosci       Date:  2022-02-11

4.  Downregulation of Circular RNA circPSD3 Promotes Metastasis by Modulating FBXW7 Expression in Clear Cell Renal Cell Carcinoma.

Authors:  Xuexia Xie; Haomin Li; Chongqing Gao; Yiqi Lai; Junjie Liang; Zhiwei Chen; Zheng Chen; Baoli Heng; Nan Yao; Caiyong Lai
Journal:  J Oncol       Date:  2022-03-07       Impact factor: 4.375

5.  Hsa_circ_0085576 promotes clear cell renal cell carcinoma tumorigenesis and metastasis through the miR-498/YAP1 axis.

Authors:  Guanghua Liu; Jingmin Zhou; Yuanlin Piao; Xin Zhao; Yuzhi Zuo; Zhigang Ji
Journal:  Aging (Albany NY)       Date:  2020-06-15       Impact factor: 5.682

6.  A novel protein encoded by circFNDC3B inhibits tumor progression and EMT through regulating Snail in colon cancer.

Authors:  Zihao Pan; Jianye Cai; Jiatong Lin; Huinian Zhou; Jingwen Peng; Jinliang Liang; Long Xia; Qi Yin; Baojia Zou; Jun Zheng; Liang Qiao; Lei Zhang
Journal:  Mol Cancer       Date:  2020-04-02       Impact factor: 27.401

Review 7.  Circular RNAs in renal cell carcinoma: implications for tumorigenesis, diagnosis, and therapy.

Authors:  Ying Wang; Yunjing Zhang; Ping Wang; Xianghui Fu; Weiqiang Lin
Journal:  Mol Cancer       Date:  2020-10-14       Impact factor: 27.401

8.  CircCSNK1G3 up-regulates miR-181b to promote growth and metastasis via TIMP3-mediated epithelial to mesenchymal transitions in renal cell carcinoma.

Authors:  Wen Li; Yang-Yi-Yan Song; Ting Rao; Wei-Min Yu; Yuan Ruan; Jin-Zhuo Ning; Xiao-Bing Yao; Song-Yi-Sha Yang; Fan Cheng
Journal:  J Cell Mol Med       Date:  2021-02-09       Impact factor: 5.295

9.  CircFNDC3B sequestrates miR-937-5p to derepress TIMP3 and inhibit colorectal cancer progression.

Authors:  Wei Zeng; Yi Liu; Wen-Ting Li; Yi Li; Jin-Feng Zhu
Journal:  Mol Oncol       Date:  2020-09-19       Impact factor: 7.449

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.